Definitive Contract 75D30122C15096
Award Date
9/30/22
Potential Completion Date
9/29/23
Potential Value
$5M
Federal Agency
CDC Pittsburgh
Awardee
Helix Opco LLC
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
AJ12 - General Science And Technology R&D Services; General Science And Technology; Applied Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Mateo, CA 94401, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
273
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Helix Opco, LLC was awarded a $10.88 million firm fixed price definitive contract by the Centers for Disease Control and Prevention (CDC) on September 17, 2021 to provide genomic sequencing services. The contract has a period of performance through May 14, 2022 and was issued without a set-aside designation. As a for-profit limited liability company located in San Mateo, California, Helix Opco will deliver the sequencing services from its place of performance in the same city. No major...
This is a $2,190,000.00 firm fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Helix Opco LLC, a for-profit limited liability company located in San Mateo, California. The contract is for FY22 BAA - TOPIC 7 - IDENTIFYING VIRAL AND HOST GENETIC DETERMINANTS OF VACCINE EFFICACY and has a period of performance ending on September 29, 2023. No set-aside designation was used. Based on Helix Opco's prior contract history, the work under this award...
This is a $81,891,810.00 definitive, firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Helix Opco LLC, a for-profit limited liability company located in San Mateo, California. The contract is for "Genomic Sequencing for COVID-19" and has a period of performance through April 28, 2025. No set-aside designation was used. Based on Helix Opco's past federal contracting history, the company has provided genomic sequencing services for COVID-19...
The Centers for Disease Control and Prevention awarded a $3.975 million firm fixed price definitive contract to Illumina, Inc. of San Diego, California. The contract is for SARS-COV-2 SPHERES Baseline Genomic Sequencing to support the Department of Health and Human Services and CDC's efforts responding to the Coronavirus Disease 2019 (COVID-19) pandemic. Under this contract, Illumina will provide genomic sequencing and data analysis services to establish a baseline of SARS-CoV-2 virus genomes...
The Centers for Disease Control and Prevention awarded a $600,000 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The contract calls for SARS-COV-2 SPHERES baseline genomic sequencing in support of the CDC's coronavirus COVID-19 programs. Performance will take place in San Diego through March 2021. As the leading public health agency in the U.S., the CDC routinely sequences virus genomes to track disease spread and evolution, providing genomic surveillance critical...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $2.5 million definitive contract to the Scripps Research Institute for genomic sequencing of SARS-CoV-2 to investigate local and cross-border emergence and spread. This contract was awarded under the Centers for Disease Control COVID-19 Broad Agency Announcement, which sought white papers related to developing strategies for protecting communities from COVID-19, including examining the virus's...
The Centers for Disease Control and Prevention (CDC) awarded a $7,303.60 firm fixed price purchase order to Illumina, Inc. to provide supplies in support of the agency's programs. The contract has a period of performance from August 14, 2023 through September 10, 2023 and will be performed in San Diego, California. As the prime contractor, Illumina will deliver supplies to the CDC's Pittsburgh location. No major subcontractors or set aside designations were identified. The funding supports the...
The Centers for Disease Control and Prevention (CDC) awarded a $19,502 purchase order to Illumina, Inc. for lab supplies under a firm fixed price contract. The CDC, a component of the Department of Health and Human Services, supports programs focused on public health and disease prevention. This award will provide Illumina the opportunity to deliver laboratory materials to assist the CDC in carrying out its important mission over the approximately two-month period of performance ending in late...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions, for the provision of lab supplies. The $16,168.00 contract has an April 29, 2024 completion date and was awarded on August 22, 2019. The lab supplies are to be delivered to the CDC's location in Atlanta, GA. Illumina is a for-profit organization and manufacturer that has previously...
This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to facilitate the relocation of equipment to accommodate COVID-19 (CORVD) operations. The $20,092.00 contract has an ultimate completion date of August 1, 2024. Illumina has a history of providing sequencing systems and associated services to support genomic research and diagnostics across various...